Binge Eating Disorder
📧 Sign up to get email alerts when something new happens for Binge Eating Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Pre-therapeutic Validation of the Virtual Reality-based Exposure Scenario for CBT "ReVBED" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder (BED) [NA]
This completed clinical trial evaluates the pre-therapeutic validation of a virtual reality-based exposure scenario (ReVBED) for cognitive b…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating [NA]
Clinical trial update describing a Drexel University study evaluating technological augmentations to enhance outcomes of self-help cognitive…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Mobile Attention Retraining in Overweight Female Adolescents [NA]
Completed clinical trial evaluating a mobile attention retraining intervention for overweight female adolescents. Results were posted on 202…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Study of Prevalence of Eating Disorder in Liver Transplant Patients
Completed clinical trial evaluating how prevalent eating disorders are among liver transplant patients, including associations with binge ea…
-
FDA approval · 2024-07-26FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sandoz Inc)
The FDA approved Sandoz Inc's original generic application for lisdexamfetamine dimesylate, authorizing its use as a stimulant medication. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Integrative Intervention Strategies for Binge Eating in Patients With Overweight or Obesity [NA]
A NOT_YET_RECRUITING clinical trial from G. d'Annunzio University examines integrative interventions for binge eating in people who are over…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Weight Loss Treatment for Veterans With Binge Eating [NA]
The VA Office of Research and Development reports a completed clinical trial evaluating a weight loss treatment for veterans with Binge Eati…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: EMDR vs. CBT in the Treatment of Inpatients With Obesity and Binge Eating Disorder: the EMDRDCA Study. [NA]
A clinical trial comparing EMDR to CBT for inpatients with obesity and binge eating disorder is currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Pilot Study on the Validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa (BN) and Binge Eating Disorders (BED)
A pilot study is underway to evaluate the validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa and Binge-Eating Disorder, a…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Feasibility of the ROADE Program [NA]
This clinical trial update reports the feasibility of the ROADE Program and indicates the trial has been terminated.
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity [NA]
A feasibility study is planned to evaluate a digital therapeutic for adults with binge eating disorder and obesity; the study status is NOT_…
-
FDA approval · 2024-06-04FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Solco Healthcare US,LLC)
FDA approved a supplemental application for lisdexamfetamine dimesylate capsules submitted by Solco Healthcare US, LLC. The approval covers …
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program [NA]
A trial update for the MINERVA program, a new treatment program for adolescents with eating disorders, currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Feasibility Trial of Getting Better Bite by Bite for Eating Disorders [NA]
A feasibility study titled 'Getting Better Bite by Bite' for eating disorders, including bulimia nervosa and binge-eating disorder, conducte…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Precursors of Binge Eating Disorder in a Clinical Sample of Adolescents With Obesity
The study is recruiting adolescents with obesity to examine precursors and risk factors for developing Binge-Eating Disorder.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Improving Weight Loss Outcomes for Binge Eating Disorder. [NA]
A Drexel University-sponsored clinical trial evaluating approaches to improve weight loss outcomes for individuals with binge eating disorde…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic [NA]
Completed clinical trial evaluating Reward Re-Training for reward imbalance in bulimia nervosa and related eating disorders; results posted …
-
FDA approval · 2024-02-14FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate (generic) from Lannett Company, Inc., enabling a new generic pro…
-
FDA approval · 2024-02-02FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original ANDA for lisdexamfetamine dimesylate (Novadoz Pharmaceuticals LLC), a generic version of the stimulant used to trea…
-
FDA approval · 2024-01-30FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for lisdexamfetamine dimesylate by Apotex Corp., approving a generic product under the supplemental …
-
FDA label_change · 2024-01-17FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lisdexamfetamine dimesylate from Hikma Pharmaceuticals USA Inc., resulting in changes to the pro…
-
FDA approval · 2024-01-05FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for lisdexamfetamine dimesylate, a generic version of the ADHD medication.
-
FDA approval · 2023-10-13FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, indicating an…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating [NA]
A completed clinical trial from Stanford University evaluating behavior change tools for smoking and binge eating using novel technologies a…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' lisdexamfetamine dimesylate as an original-application generic product under ANDA 217068.